Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future

키워드

참고문헌 (47)

1. Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
2. Kwon SU, "Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis", Stroke, 42, pp.2883~2890 (2011)
3. Kasner SE, "Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis", Circulation, 113, pp.555~563 (2006)
4. Sundt TM Jr, "Transluminal angioplasty for basilar artery stenosis", Mayo Clin Proc, 55, pp.673~680 (1980)
5. Higashida RT, "Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries", J Neurosurg, 78, pp.192~198 (1993)
6. Clark WM, "Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis", Stroke, 26, pp.1200~1204 (1995)
7. Connors JJ 3rd, "Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results", J Neurosurg, 91, pp.415~423 (1999)
8. Gress DR, "Angioplasty for intracranial symptomatic vertebrobasilar ischemia", Neurosurgery, 51, pp.23~27 (2002)
9. Gupta R, "Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis", Neurology, 61, pp.1729~1735 (2003)
10. Marks MP, "Angioplasty for symptomatic intracranial stenosis: clinical outcome", Stroke, 37, pp.1016~1020 (2006)
11. Jiang WJ, "Stenting of symptomatic M1 stenosis of middle cerebral artery:an initial experience of 40 patients", Stroke, 35, pp.1375~1380 (2004)
12. de Rochemont Rdu M, "Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience", Radiology, 231, pp.45~49 (2004)
13. Kim JK, "Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks:short term arteriographical and clinical outcome", J Neurol Neurosurg Psychiatry, 75, pp.847~851 (2004)
14. SSYLVIA Study Investigators, "Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results", Stroke, 35, pp.1388~1392 (2004)
15. Bose A, "A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study", Stroke, 38, pp.1531~1537 (2007)
16. Zaidat OO, "The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis", Neurology, 70, pp.1518~1524 (2008)
17. Nahab F, "Risk factors associated with major cerebrovascular complications after intracranial stenting", Neurology, 72, pp.2014~2019 (2009)
18. Fiorella D, "Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)", Stroke, 43, pp.2682~2688 (2012)
19. Chimowitz MI, "Stenting versus aggressive medical therapy for intracranial arterial stenosis", N Engl J Med, 365, pp.993~1003 (2011)
20. Zaidat OO, "Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial", JAMA, 313, pp.1240~1248 (2015)
21. Chimowitz MI, "Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial", J Stroke Cerebrovasc Dis, 20, pp.357~368 (2011)
22. Derdeyn CP, "Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial", Lancet, 383, pp.333~341 (2014)
23. Lutsep HL, "Does the stenting versus aggressive medical therapy trial support stenting for subgroups with intracranial stenosis?", Stroke, 46, pp.3282~3284 (2015)
24. Fiorella D, "US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results", Stroke, 38, pp.881~887 (2007)
25. Miao Z, "Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China", Stroke, 46, pp.2822~2829 (2015)
26. Suri MF, "Epidemiology of intracranial stenosis", J Neuroimaging, 19(Suppl 1), pp.11S~16S (2009)
27. Derdeyn CP, "Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial", J Neurointerv Surg, 5, pp.528~533 (2013)
28. Niu JW, "Intracranial atherosclerosis in Chinese young adult stroke patients", J Stroke Cerebrovasc Dis, 23, pp.1519~1523 (2014)
29. Ssi-Yan-Kai G, "Intracranial artery stenosis or occlusion predicts ischemic recurrence after transient ischemic attack", AJNR Am J Neuroradiol, 34, pp.185~190 (2013)
30. Waters MF, "Factors associated with recurrent ischemic stroke in the medical group of the SAMMPRIS trial", JAMA Neurol, 73, pp.308~315 (2016)
31. Suh DC, "Intracranial stenting of severe symptomatic intracranial stenosis:results of 100 consecutive patients", AJNR Am J Neuroradiol, 29, pp.781~785 (2008)
32. Derdeyn CP, "Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial", Neurosurgery, 72, pp.777~795 (2013)
33. Chaudhry SA, "The new standard for performance of intracranial angioplasty and stent placement after Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) trial", AJNR Am J Neuroradiol, 32, pp.E214~ (2011)
34. Levy EI, "Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management", Neurosurgery, 61, pp.644~650 (2007)
35. Park S, "Long-term outcomes of drug-eluting stents in symptomatic intracranial stenosis", Neurointervention, 8, pp.9~14 (2013)
36. Qureshi AI, "Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis", Neurosurgery, 59, pp.1044~1051 (2006)
37. Abou-Chebl A, "Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up", Stroke, 36, pp.e165~e168 (2005)
38. Gupta R, "Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation", Stroke, 37, pp.2562~2566 (2006)
39. Lopez-Cancio E, "Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis", Cerebrovasc Dis, 37, pp.417~422 (2014)
40. Liebeskind DS, "Collaterals dramatically alter stroke risk in intracranial atherosclerosis", Ann Neurol, 69, pp.963~974 (2011)
41. Mazighi M, "Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study", Neurology, 66, pp.1187~1191 (2006)
42. Amin-Hanjani S, "Effect of hemodynamics on stroke risk in symptomatic atherosclerotic vertebrobasilar occlusive disease", JAMA Neurol, 73, pp.178~185 (2016)
43. Cui XP, "Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis:study protocol of a randomised controlled trial", BMJ Open, 6, pp.e012175~ (2016)
44. Rassaf T, "Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning", Circ Res, 114, pp.1601~1610 (2014)
45. Liu C, "Mechanisms of human erythrocytic bioactivation of nitrite", J Biol Chem, 290, pp.1281~1294 (2015)
46. Meng R, "Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis", Neurology, 79, pp.1853~1861 (2012)
47. Meng R, "Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment", Neurotherapeutics, 12, pp.667~677 (2015)

관련 논문AI추천